Pulmonary Involvement in Sjögren Syndrome

Clinics in Chest Medicine

Volumn 31, Issue 3, 2010, Pages 489-500

  Kokosi, Maria ^a   Riemer, Ellen C ^b   Highland, Kristin B ^b  

^a SISMANOGLIO HOSPITAL   (Greece)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Airway disease; Interstitial lung disease; Lymphocytic interstitial pneumonitis; Lymphoma; Sj gren syndrome

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

AMYLOIDOSIS; ARTHRALGIA; B CELL LYMPHOMA; BRONCHIOLITIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE ASSOCIATION; DRUG EFFICACY; DYSPNEA; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOMA; PATHOGENESIS; PLEURA EFFUSION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOLYMPHOMA; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; SJOEGREN SYNDROME; THORAX RADIOGRAPHY; XEROBRONCHITIS; XEROTRACHEA;

EID: 77955360922     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2010.05.007     Document Type: Review

References (68)

1. Gabriel S.E., Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009, 11:229.
2. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
3. Ferreiro J.E., Pasarin G., Quesada R., et al. Benign hypergammaglobulinemic purpura of Waldenstrom associated with Sjogren's syndrome. Case report and review of immunologic aspects. Am J Med 1986, 81:734-740.
4. Tzioufas A.G., Voulgarelis M. Update on Sjogren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 2007, 21:989-1010.
5. Bolstad A.I., Wassmuth R., Haga H.J., et al. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome. J Rheumatol 2001, 28:1554-1562.
6. Alexander E.L., Arnett F.C., Provost T.T., et al. Sjogren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983, 98:155-159.
7. Schaumberg D.A., Buring J.E., Sullivan D.A., et al. Hormone replacement therapy and dry eye syndrome. JAMA 2001, 286:2114-2119.
8. Fox R.I. Sjogren's syndrome. Lancet 2005, 366:321-331.
9. Dawson L., Tobin A., Smith P., et al. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?. Arthritis Rheum 2005, 52:2984-2995.
10. Mitsias D.I., Kapsogeorgou E.K., Moutsopoulos H.M. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren's syndrome (autoimmune epithelitis). Lupus 2006, 15:255-261.
11. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
12. Strimlan C.V., Rosenow E.C., Divertie M.B., et al. Pulmonary manifestations of Sjogren's syndrome. Chest 1976, 70:354-361.
13. Constantopoulos S.H., Papadimitriou C.S., Moutsopoulos H.M. Respiratory manifestations in primary Sjogren's syndrome. A clinical, functional, and histologic study. Chest 1985, 88:226-229.
14. Yazisiz V., Arslan G., Ozbudak I.H., et al. Lung involvement in patients with primary Sjogren's syndrome: what are the predictors?. Ann Rheum Dis 2002, 61(6):554-558.
15. Pertovaara M., Korpela M., Saarelainen S., et al. Long-term follow-up study of pulmonary findings in patients with primary Sjogren's syndrome. Scand J Rheumatol 2004, 33:343-348.
16. Uffmann M., Kiener H.P., Bankier A.A., et al. Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 2001, 16:282-289.
17. Papiris S.A., Maniati M., Constantopoulos S.H., et al. Lung involvement in primary Sjogren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999, 58:61-64.
18. Parambil J.G., Myers J.L., Lindell R.M., et al. Interstitial lung disease in primary Sjogren syndrome. Chest 2006, 130:1489-1495.
19. Ito I., Nagai S., Kitaichi M., et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005, 171:632-638.
20. Kelly C., Gardiner P., Pal B., et al. Lung function in primary Sjogren's syndrome: a cross sectional and longitudinal study. Thorax 1991, 46:180-183.
21. Taouli B., Brauner M.W., Mourey I., et al. Thin-section chest CT findings of primary Sjogren's syndrome: correlation with pulmonary function. Eur Radiol 2002, 12:1504-1511.
22. Dalavanga Y.A., Constantopoulos S.H., Galanopoulou V., et al. Alveolitis correlates with clinical pulmonary involvement in primary Sjogren's syndrome. Chest 1991, 99:1394-1397.
23. Salaffi F., Manganelli P., Carotti M., et al. A longitudinal study of pulmonary involvement in primary Sjogren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol 1998, 37:263-269.
24. Franquet T., Gimenez A., Monill J.M., et al. Primary Sjogren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997, 169:655-658.
25. Koyama M., Johkoh T., Honda O., et al. Pulmonary involvement in primary Sjogren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 2001, 16:290-296.
26. Franquet T., Diaz C., Domingo P., et al. Air trapping in primary Sjogren syndrome: correlation of expiratory CT with pulmonary function tests. J Comput Assist Tomogr 1999, 23:169-173.
27. Freeman S.R., Sheehan P.Z., Thorpe M.A., et al. Ear, nose, and throat manifestations of Sjogren's syndrome: retrospective review of a multidisciplinary clinic. J Otolaryngol 2005, 34:20-24.
28. Papiris S.A., Saetta M., Turato G., et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome. Am J Respir Crit Care Med 1997, 156:637-641.
29. Lahdensuo A., Korpela M. Pulmonary findings in patients with primary Sjogren's syndrome. Chest 1995, 108:316-319.
30. Gudbjornsson B., Hedenstrom H., Stalenheim G., et al. Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren's syndrome. Ann Rheum Dis 1991, 50:36-40.
31. Amin K., Ludviksdottir D., Janson C., et al. Inflammation and structural changes in the airways of patients with primary Sjogren's syndrome. Respir Med 2001, 95:904-910.
32. Wells A.U., du Bois R.M. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993, 14:655-666.
33. Yamadori I., Fujita J., Bandoh S., et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren's syndrome. Rheumatol Int 2002, 22:89-92.
34. Fujita J., Yamadori I., Suemitsu I., et al. Clinical features of non-specific interstitial pneumonia. Respir Med 1999, 93:113-118.
35. Travis W.D., Hunninghake G., King T.E., et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008, 177:1338-1347.
36. Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994, 18:136-147.
37. Cha S.I., Fessler M.B., Cool C.D., et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006, 28:364-369.
38. Johkoh T., Muller N.L., Pickford H.A., et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999, 212:567-572.
39. Dalvi V., Gonzalez E.B., Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjogren's syndrome: a case report and a review of the literature. Clin Rheumatol 2007, 26:1339-1343.
40. Kadota J., Kusano S., Kawakami K., et al. Usual interstitial pneumonia associated with primary Sjogren's syndrome. Chest 1995, 108:1756-1758.
41. Matteson E.L., Ike R.W. Bronchiolitis obliterans organizing pneumonia and Sjogren's syndrome. J Rheumatol 1990, 17:676-679.
42. Usui Y., Kimula Y., Miura H., et al. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjogren's syndrome who died of superimposed diffuse alveolar damage. Respiration 1992, 59:122-124.
43. Lambert M., Hebbar M., Viget N., et al. Rev Med Interne 2000, 21:74-77. [in French].
44. Ioannou S., Toya S.P., Tomos P., et al. Cryptogenic organizing pneumonia associated with primary Sjogren's syndrome. Rheumatol Int 2008, 28:1053-1055.
45. Kassan S.S., Thomas T.L., Moutsopoulos H.M., et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978, 89:888-892.
46. Voulgarelis M., Dafni U.G., Isenberg D.A., et al. Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's syndrome. Arthritis Rheum 1999, 42:1765-1772.
47. Tonami H., Matoba M., Kuginuki Y., et al. Clinical and imaging findings of lymphoma in patients with Sjogren syndrome. J Comput Assist Tomogr 2003, 27:517-524.
48. Voulgarelis M., Tzioufas A.G., Moutsopoulos H.M. Mortality in Sjogren's syndrome. Clin Exp Rheumatol 2008, 26:S66-S71.
49. Hansen L.A., Prakash U.B., Colby T.V. Pulmonary lymphoma in Sjogren's syndrome. Mayo Clin Proc 1989, 64:920-931.
50. Sunada K., Hasegawa Y., Kodama T., et al. Thymic and pulmonary mucosa-associated lymphoid tissue lymphomas in a patient with Sjogren's syndrome and literature review. Respirology 2007, 12:144-147.
51. Song M.K., Seol Y.M., Park Y.E., et al. Pulmonary nodular lymphoid hyperplasia associated with Sjogren's syndrome. Korean J Intern Med 2007, 22:192-196.
52. Jeong Y.J., Lee K.S., Chung M.P., et al. Amyloidosis and lymphoproliferative disease in Sjogren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr 2004, 28:776-781.
53. Adzic T.N., Stojsic J.M., Radosavljevic-Asic G.D., et al. Multinodular pulmonary amyloidosis in primary Sjogren's syndrome. Eur J Intern Med 2008, 19:e97-e98.
54. Bertoni M., Niccoli L., Porciello G., et al. Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. Clin Rheumatol 2005, 24:431-434.
55. Hedgpeth M.T., Boulware D.W. Pulmonary hypertension in primary Sjogren's syndrome. Ann Rheum Dis 1988, 47:251-253.
56. Launay D., Hachulla E., Hatron P.Y., et al. Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007, 86:299-315.
57. Bouros D., Pneumatikos I., Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008, 75:361-371.
58. Perez-Castrillon J.L., Gonzalez-Castaneda C., Del Campo F., et al. Cavitary lung lesion in a patient with Sjogren's syndrome. Postgrad Med J 1999, 75:765-766.
59. Hubscher O., Re R., Iotti R. Cystic lung disease in Sjogren's syndrome. J Rheumatol 2002, 29:2235-2236.
60. Isaksen K., Jonsson R., Omdal R. Anti-CD20 treatment in primary Sjogren's syndrome. Scand J Immunol 2008, 68:554-564.
61. Seror R., Sordet C., Guillevin L., et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome. Ann Rheum Dis 2007, 66:351-357.
62. Voulgarelis M., Giannouli S., Tzioufas A.G., et al. Long term remission of Sjogren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis 2006, 65:1033-1037.
63. Pijpe J., van Imhoff G.W., Vissink A., et al. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma. Ann Rheum Dis 2005, 64:958-960.
64. Mariette X., Ravaud P., Steinfeld S., et al. Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS). Arthritis Rheum 2004, 50:1270-1276.
65. Steinfeld S.D., Demols P., Salmon I., et al. Infliximab in patients with primary Sjogren's syndrome: a pilot study. Arthritis Rheum 2001, 44:2371-2375.
66. Sankar V., Brennan M.T., Kok M.R., et al. Etanercept in Sjogren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 2004, 50:2240-2245.
67. Roescher N., Tak PP., Illei GG. Cytokines in Sjogren's syndrome: potential therapeutic targets. Ann Rheum Dis 2010, 69:945-948.
68. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.